Nutriband Inc. (NASDAQ:NTRBW – Get Free Report)’s share price dropped 9.7% on Thursday . The company traded as low as $1.40 and last traded at $1.40. Approximately 8,275 shares were traded during trading, an increase of 183% from the average daily volume of 2,922 shares. The stock had previously closed at $1.55.
Nutriband Price Performance
The stock has a 50-day moving average price of $1.56 and a 200 day moving average price of $1.70.
Institutional Trading of Nutriband
An institutional investor recently bought a new position in Nutriband stock. Clear Street Group Inc. bought a new position in Nutriband Inc. (NASDAQ:NTRBW – Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 61,590 shares of the company’s stock, valued at approximately $105,000.
About Nutriband
Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility.
See Also
- Five stocks we like better than Nutriband
- The $5 vs. $800 Billion trade
- Think You Missed Silver? You’re Wrong. Here’s Why.
- Trump’s AI Secret: 100X Faster Than Nvidia
- Your Bank Account Is No Longer Safe
- ALERT: Drop these 5 stocks before the market opens tomorrow!
Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.
